Paper20150892
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.
Drosten M and 9 others. EMBO J, 2010. Cited by 295 papers, by iCite.
Cite this record
ConductScience Library. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. Papers, record 20150892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20150892
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| Signal Transduction | Major topic |
| ras Proteins | Major topic |
| Animals | |
| Cell Movement | |
| Cell Survival | |
| Extracellular Signal-Regulated MAP Kinases | |
| Fibroblasts | |
| Mice | |
| Phosphatidylinositol 3-Kinases | |
| raf Kinases |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10557073 | Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. | Oncogene | 1999 | https://conductscience.org/library/papers/10557073 | PubMed |
| 2 | 10022812 | Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. | Oncogene | 1999 | https://conductscience.org/library/papers/10022812 | PubMed |
| 3 | 16226508 | The role of erk1 and erk2 in multiple stages of T cell development. | Immunity | 2005 | https://conductscience.org/library/papers/16226508 | PubMed |
| 4 | 9199319 | Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. | Mol Cell Biol | 1997 | https://conductscience.org/library/papers/9199319 | PubMed |
| 5 | 9362489 | Stimulation of gene induction and cell growth by the Ras effector Rlf. | EMBO J | 1997 | https://conductscience.org/library/papers/9362489 | PubMed |
| 6 | 9150145 | Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. | Cell | 1997 | https://conductscience.org/library/papers/9150145 | PubMed |
| 7 | 9765202 | Senescence of human fibroblasts induced by oncogenic Raf. | Genes Dev | 1998 | https://conductscience.org/library/papers/9765202 | PubMed |
| 8 | 14519393 | Role of Rho-family proteins in cell adhesion and cancer. | Curr Opin Cell Biol | 2003 | https://conductscience.org/library/papers/14519393 | PubMed |
| 9 | 10558995 | Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. | Science | 1999 | https://conductscience.org/library/papers/10558995 | PubMed |
| 10 | 7651428 | RAS signalling is abnormal in a c-raf1 MEK1 double mutant. | Mol Cell Biol | 1995 | https://conductscience.org/library/papers/7651428 | PubMed |
| 11 | 9825675 | Genetics of RAS signaling in C. elegans. | Trends Genet | 1998 | https://conductscience.org/library/papers/9825675 | PubMed |
| 12 | 11257001 | Analysis of R-Ras signalling pathways. | J Cell Sci | 2001 | https://conductscience.org/library/papers/11257001 | PubMed |
| 13 | 10880430 | The ErbB signaling network: receptor heterodimerization in development and cancer. | EMBO J | 2000 | https://conductscience.org/library/papers/10880430 | PubMed |
| 14 | 3145408 | Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/3145408 | PubMed |
| 15 | 17182900 | Rap1: a key regulator in cell-cell junction formation. | J Cell Sci | 2007 | https://conductscience.org/library/papers/17182900 | PubMed |
| 16 | 15950907 | Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). | Cancer Cell | 2005 | https://conductscience.org/library/papers/15950907 | PubMed |
| 17 | 12778136 | RAS oncogenes: the first 30 years. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12778136 | PubMed |
| 18 | 14645534 | While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14645534 | PubMed |
| 19 | 19243428 | Compartmentalized signalling: Ras proteins and signalling nanoclusters. | FEBS J | 2009 | https://conductscience.org/library/papers/19243428 | PubMed |
| 20 | 9294608 | K-ras is essential for the development of the mouse embryo. | Oncogene | 1997 | https://conductscience.org/library/papers/9294608 | PubMed |
Cited by220
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794624 | Integrated Analysis of Rat Pulmonary Hypertension Datasets Identifies Candidate circRNA Networks in Hypoxia-Exposed Pulmonary Artery Tissue. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794624 | PubMed |
| 42749263 | A RALGEF inhibitor suppresses lung cancer stem cell development and tumorigenesis. | J Biol Chem | 2026 | https://conductscience.org/library/papers/42749263 | PubMed |
| 42709866 | HRAS promotes mutant NRAS-driven transformation with codon and allele specificity. | Sci Signal | 2026 | https://conductscience.org/library/papers/42709866 | PubMed |
| 42653163 | Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653163 | PubMed |
| 42649211 | Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649211 | PubMed |
| 42439612 | Understanding the Role of Fibrotic Scarring in Shaping the Lesion Site and Neural Repair After Spinal Cord Injury. | Cells | 2026 | https://conductscience.org/library/papers/42439612 | PubMed |
| 42303154 | KRAS G12C and KRAS G12D respond to lipid metabolism in an allele-specific manner. | J Lipid Res | 2026 | https://conductscience.org/library/papers/42303154 | PubMed |
| 42297776 | Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42297776 | PubMed |
| 42201959 | NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42201959 | PubMed |
| 42200804 | Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis. | Cancer Res | 2026 | https://conductscience.org/library/papers/42200804 | PubMed |
| 42082482 | Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant models. | Nat Commun | 2026 | https://conductscience.org/library/papers/42082482 | PubMed |
| 42079131 | Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer. | bioRxiv | 2026 | https://conductscience.org/library/papers/42079131 | PubMed |
| 42054419 | Computational insights on the molecular interplay between KRas (G12D mutation) and SOS1 modulated by the inhibitor BI-3406. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42054419 | PubMed |
| 42017331 | Revisiting RAS family GTPase signaling: effector selectivity and oncogenic bypass. | Biochem J | 2026 | https://conductscience.org/library/papers/42017331 | PubMed |
| 41882629 | SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41882629 | PubMed |
| 41819089 | De novo design of Ras isoform selective binders. | Cell Chem Biol | 2026 | https://conductscience.org/library/papers/41819089 | PubMed |
| 41685162 | Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685162 | PubMed |
| 41556816 | KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment. | Cancer Res | 2026 | https://conductscience.org/library/papers/41556816 | PubMed |
| 41513618 | MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41513618 | PubMed |
| 41340466 | Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer. | Mol Cancer Ther | 2026 | https://conductscience.org/library/papers/41340466 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20150892
GET https://conductscience.org/api/papers/v1/20150892/references?page=2